Optimization and validation of an ischemic wound model

Lisa J. Gould, Mimi Leong, Joseph Sonstein, Shelly Wilson

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Localized tissue ischemia is a key factor in the development and poor prognosis of chronic wounds. Currently, there are no standardized animal models that provide sufficient tissue to evaluate the effect of modalities that may induce angiogenesis, and in vitro models of angiogenesis do not mimic the complexity of the ischemic wound bed. Therefore, we set out to develop a reproducible ischemic model for use in wound-healing studies. Male Sprague-Dawley rats underwent creation of dorsal bipedicle skin flaps with centrally located excisional wounds. Oxygen tension, wound-breaking strength, wound area, lactate, and wound vascular endothelial growth factor (VEGF) were compared in flaps measuring 2.5 and 2.0 × 11 cm with and without an underlying silicone sheet. We found that the center of the 2.0 cm flap with silicone remains in the critically ischemic range up to 14 days without tissue necrosis (33±4 vs. 49±6 mmHg in controls). Wound healing and breaking strength were significantly impaired and tissue lactate from the center of this flap was 2.9 times greater than tissue from either nonischemic controls and 2.5 cm flap (0.23±0.05 mg/dL/mg sample vs. 0.09±0.02 and 0.08±0.02, respectively). Vascular endothelial growth factor was 2 times greater than the nonischemic control. This ischemic wound model is relatively inexpensive, easy to perform, reproducible, and reliable. The excisional wounds provide sufficient tissue for biochemical and histologic analysis, and are amenable to the evaluation of topical and systemic therapies that may induce angiogenesis or improve wound healing.

Original languageEnglish (US)
Pages (from-to)576-582
Number of pages7
JournalWound Repair and Regeneration
Volume13
Issue number6
DOIs
StatePublished - Nov 2005

Fingerprint

Wounds and Injuries
Wound Healing
Silicones
Vascular Endothelial Growth Factor A
Lactic Acid
Sprague Dawley Rats
Necrosis
Ischemia
Animal Models
Oxygen
Skin
Therapeutics

ASJC Scopus subject areas

  • Dermatology
  • Surgery

Cite this

Optimization and validation of an ischemic wound model. / Gould, Lisa J.; Leong, Mimi; Sonstein, Joseph; Wilson, Shelly.

In: Wound Repair and Regeneration, Vol. 13, No. 6, 11.2005, p. 576-582.

Research output: Contribution to journalArticle

Gould, Lisa J. ; Leong, Mimi ; Sonstein, Joseph ; Wilson, Shelly. / Optimization and validation of an ischemic wound model. In: Wound Repair and Regeneration. 2005 ; Vol. 13, No. 6. pp. 576-582.
@article{b249da6fd3294ad9b77e1ef160451c01,
title = "Optimization and validation of an ischemic wound model",
abstract = "Localized tissue ischemia is a key factor in the development and poor prognosis of chronic wounds. Currently, there are no standardized animal models that provide sufficient tissue to evaluate the effect of modalities that may induce angiogenesis, and in vitro models of angiogenesis do not mimic the complexity of the ischemic wound bed. Therefore, we set out to develop a reproducible ischemic model for use in wound-healing studies. Male Sprague-Dawley rats underwent creation of dorsal bipedicle skin flaps with centrally located excisional wounds. Oxygen tension, wound-breaking strength, wound area, lactate, and wound vascular endothelial growth factor (VEGF) were compared in flaps measuring 2.5 and 2.0 × 11 cm with and without an underlying silicone sheet. We found that the center of the 2.0 cm flap with silicone remains in the critically ischemic range up to 14 days without tissue necrosis (33±4 vs. 49±6 mmHg in controls). Wound healing and breaking strength were significantly impaired and tissue lactate from the center of this flap was 2.9 times greater than tissue from either nonischemic controls and 2.5 cm flap (0.23±0.05 mg/dL/mg sample vs. 0.09±0.02 and 0.08±0.02, respectively). Vascular endothelial growth factor was 2 times greater than the nonischemic control. This ischemic wound model is relatively inexpensive, easy to perform, reproducible, and reliable. The excisional wounds provide sufficient tissue for biochemical and histologic analysis, and are amenable to the evaluation of topical and systemic therapies that may induce angiogenesis or improve wound healing.",
author = "Gould, {Lisa J.} and Mimi Leong and Joseph Sonstein and Shelly Wilson",
year = "2005",
month = "11",
doi = "10.1111/j.1524-475X.2005.00080.x",
language = "English (US)",
volume = "13",
pages = "576--582",
journal = "Wound Repair and Regeneration",
issn = "1067-1927",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Optimization and validation of an ischemic wound model

AU - Gould, Lisa J.

AU - Leong, Mimi

AU - Sonstein, Joseph

AU - Wilson, Shelly

PY - 2005/11

Y1 - 2005/11

N2 - Localized tissue ischemia is a key factor in the development and poor prognosis of chronic wounds. Currently, there are no standardized animal models that provide sufficient tissue to evaluate the effect of modalities that may induce angiogenesis, and in vitro models of angiogenesis do not mimic the complexity of the ischemic wound bed. Therefore, we set out to develop a reproducible ischemic model for use in wound-healing studies. Male Sprague-Dawley rats underwent creation of dorsal bipedicle skin flaps with centrally located excisional wounds. Oxygen tension, wound-breaking strength, wound area, lactate, and wound vascular endothelial growth factor (VEGF) were compared in flaps measuring 2.5 and 2.0 × 11 cm with and without an underlying silicone sheet. We found that the center of the 2.0 cm flap with silicone remains in the critically ischemic range up to 14 days without tissue necrosis (33±4 vs. 49±6 mmHg in controls). Wound healing and breaking strength were significantly impaired and tissue lactate from the center of this flap was 2.9 times greater than tissue from either nonischemic controls and 2.5 cm flap (0.23±0.05 mg/dL/mg sample vs. 0.09±0.02 and 0.08±0.02, respectively). Vascular endothelial growth factor was 2 times greater than the nonischemic control. This ischemic wound model is relatively inexpensive, easy to perform, reproducible, and reliable. The excisional wounds provide sufficient tissue for biochemical and histologic analysis, and are amenable to the evaluation of topical and systemic therapies that may induce angiogenesis or improve wound healing.

AB - Localized tissue ischemia is a key factor in the development and poor prognosis of chronic wounds. Currently, there are no standardized animal models that provide sufficient tissue to evaluate the effect of modalities that may induce angiogenesis, and in vitro models of angiogenesis do not mimic the complexity of the ischemic wound bed. Therefore, we set out to develop a reproducible ischemic model for use in wound-healing studies. Male Sprague-Dawley rats underwent creation of dorsal bipedicle skin flaps with centrally located excisional wounds. Oxygen tension, wound-breaking strength, wound area, lactate, and wound vascular endothelial growth factor (VEGF) were compared in flaps measuring 2.5 and 2.0 × 11 cm with and without an underlying silicone sheet. We found that the center of the 2.0 cm flap with silicone remains in the critically ischemic range up to 14 days without tissue necrosis (33±4 vs. 49±6 mmHg in controls). Wound healing and breaking strength were significantly impaired and tissue lactate from the center of this flap was 2.9 times greater than tissue from either nonischemic controls and 2.5 cm flap (0.23±0.05 mg/dL/mg sample vs. 0.09±0.02 and 0.08±0.02, respectively). Vascular endothelial growth factor was 2 times greater than the nonischemic control. This ischemic wound model is relatively inexpensive, easy to perform, reproducible, and reliable. The excisional wounds provide sufficient tissue for biochemical and histologic analysis, and are amenable to the evaluation of topical and systemic therapies that may induce angiogenesis or improve wound healing.

UR - http://www.scopus.com/inward/record.url?scp=33646097713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646097713&partnerID=8YFLogxK

U2 - 10.1111/j.1524-475X.2005.00080.x

DO - 10.1111/j.1524-475X.2005.00080.x

M3 - Article

VL - 13

SP - 576

EP - 582

JO - Wound Repair and Regeneration

JF - Wound Repair and Regeneration

SN - 1067-1927

IS - 6

ER -